OpenAI and Anthropic have called for federal AI rules, but CT officials say companies cannot shape oversight themselves.
Existential threat experts, tech CEOs and politicians fear rapidly advancing artificial intelligence technology could end ...
AI developers are increasingly concerned about losing control of these systems. We examine Dario Amodei’s essay, responses ...
Artificial intelligence (AI) is rapidly penetrating the core domain of pharmaceutical research and development (R&D), driving ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results